Archives

by in
Entry Author Date Location
BioPharma Needs A Safe, Reliable Way To Repair Broken Genes 04/11/12 Seattle
SD Life Sciences Roundup: Celladon, Gen-Probe, Organovo, and More 02/16/12 National
RetroSense Therapeutics Licenses Vision Restoration Technology From Wayne State 11/01/11 Detroit
Upping the Ante: San Diego Life Sciences Startups Raise More Cash 09/07/11 San Diego
Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News 07/21/11 San Diego
Neurologix Forges Ahead on Gene Therapy Treatment for Parkinson’s 06/23/11 New York
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News 05/27/11 Boston
Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy 05/23/11 Boston
Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting 05/23/11 San Francisco
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate 04/20/11 Boston
Bluebird Bio Inks AFM Development Deal 03/16/11 Boston
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News 03/10/11 Seattle
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London 03/09/11 Seattle
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort 02/15/11 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Targeted Genetics Seeks Merger 11/12/10 Seattle
Ceregene Adds $11.5M 11/11/10 San Diego
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker 10/18/10 San Francisco
Xconomy Boston’s Top 20 Stories of the Third Quarter: From A123 Expansion to Zynga Acquisition 10/01/10 Boston
Bluebird Bio, Third Rock & Genzyme’s Gene Therapy Bet, Shows Promise for Blood Disorder 09/15/10 Boston
Seattle Children’s Moves in at Prominent Biotech Address as Targeted Genetics Moves Out 08/18/10 Seattle
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop 08/12/10 San Francisco
Gail Maderis, the Boston Biotech Exec Who Came Home to SF, Seeks to Give Back at BayBio 07/08/10 San Francisco
Ceregene Gets $2.5M From Fox Foundation 06/23/10 San Diego
Feds’ Sequenom Probe Breaks Into the Open, Life Technologies Moves Into Synthetic Biology, DexCom Agrees to Re-Label Its Medical Devices, & More San Diego Life Sciences News 06/03/10 San Diego
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study 06/01/10 San Diego
Celladon Enjoys Early Success With Gene Therapy Trial, FDA Gives Digirad Green Light for a Nuclear Camera, Aragon Pharmaceuticals Gets $22M & More San Diego Biotech News 04/29/10 San Diego
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details 04/28/10 San Diego
Sensata and Aveo Go Public; Genetix, Rhythm, and CorrelSense Get Funding; Pegasystems to Acquire Chordiant; & More Boston-Area Deals News 03/17/10 Boston
Page 3 of 5 « previous page · next page »